May 20, 2026 09:40 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Big relief signal for Umar Khalid, Sharjeel Imam? Supreme Court questions earlier bail denial | Left era ends in Kerala! V.D. Satheesan takes oath as CM after UDF’s massive comeback | Drone strike near UAE nuclear plant sparks panic—India calls it a ‘dangerous escalation' | Kathak to Garba: Indian diaspora stuns PM Modi with grand welcome in Amsterdam | ‘Geography or history’: Indian Army chief issues blunt warning to Pakistan over terror support | India, UAE ink key energy deals during Modi’s visit amid West Asia tensions | ‘There can be no better Bengal CM’: Mithun Chakraborty praises Suvendu Adhikari | PM Modi adviser Sanjeev Sanyal frontrunner for Bengal Finance Minister: Report | FIR against Abhishek Banerjee over ‘provocative speeches’ during West Bengal poll campaign | Madhya Pradesh High Court holds Bhojshala complex disputed site to be a temple
Weight loss
Study finds weight loss causes significant muscle loss. Photo: Unsplash

Losing weight? You might be losing muscle faster than you think

| @indiablooms | Apr 18, 2026, at 05:38 pm

A new UNC School of Medicine study of incretin-based medications, including newer medications such as semaglutide and tirzepatide that are widely prescribed for Type 2 diabetes and obesity, are associated with high rates of muscle loss relative to the amount of weight lost.

John A. Batsis, MD, an expert on obesity and nutrition at the UNC School of Medicine and the UNC Gillings School of Public Health, published his team’s findings in Annals of Internal Medicine.

“While muscle loss is expected during weight loss, we observed that the proportion of weight loss attributable to muscle was consistently higher than anticipated across studies,” said Batsis. “These findings suggest that the magnitude of muscle loss relative to total weight loss warrants closer attention.”

Batsis and his team advise clinicians to carefully monitor patient’s muscle health when advising intentional weight loss.

The findings underscore a need for muscle evaluations and measurements in clinical trials, as well as more trials geared towards older adults taking semaglutide, tirzepatide, and other similar medications.

“Few current studies include participants older than 60 years, and none focused on adults aged 65 years or older,” said Batsis. “Significant muscle loss can lead to a higher fall risk, so additional trials specifically designed to evaluate aging-related outcomes that include mobility and quality of life are urgently needed.”

The findings were presented by Batsis at the breaking news scientific plenary session “New in Annals of Internal Medicine: Hear it First from the Authors” in San Francisco, California, during the American College of Physicians’ (ACP) Internal Medicine Meeting.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.